secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001295947-21-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Healthcare Q1 revenue $269.2M (+17.3%), EPS $1.14 (+32.5%); raises FY22 outlook
--------------------------------------------------------------------------------

- Revenue $269.2M, up 17.3% YoY; diluted EPS $1.14, up 32.5% vs prior year.
- North American OTC revenue $242.4M; International OTC $26.8M, up 43% from $18.7M.
- Raising FY22 guidance: revenue ~$1.045B+ (prev. $957-962M), adj. EPS $3.90+ (prev. $3.58+).
- TheraTears acquisition closed July 1, expected to add ~$40M revenue and $0.07 EPS to FY22.
- Net cash from ops $69.3M, free cash flow $67.8M; net debt ~$1.4B; refinanced term loan to 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594721000027/0001295947-21-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594721000027/pbh-20210805.htm
  HTML page:      https://secwatch.observer/filing/0001295947-21-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer